Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Anti-TNF agent etanercept augments UV-induced skin cancer development in SKH-1 mice
By
- AMS
posted
Jan 07, 2020 02:05 AM
0
Recommend
Volume 32, Issue 7
, November 2021, Page 812-818
.
0 comments
0 views
Related Content
The therapeutic effects of blocking IGF-R1 on mice model of skin cancer
- AMS
Added Jan 04, 2020
Blog Entry
Liraglutide improved inflammation via mediating IL-23/Th-17 pathway in obese diabetic mice with psoriasiform skin
- AMS
Added Jan 04, 2020
Blog Entry
Emerging novel therapeutic agents for the treatment of patients with prurigo nodularis
- AMS
Added Jan 04, 2020
Blog Entry
Prevalence and treatment outcomes of skin infections among elderly population: a retrospective cross-sectional study
- AMS
Added Mar 06, 2020
Blog Entry
Glycerol 85% efficacy on atopic skin and its microbiome: a randomized controlled trial with clinical and bacteriological evaluation
- AMS
Added Jan 06, 2020
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic